End-to-end offering is designed to streamline site activation and optimize visibility in critical research processes.
Use of decentralized approach in a Phase 1 pharmacokinetic trial shows the ability to enable remote data collection and ...
In this video interview, Dipanwita Das, CEO & co-founder at Sorcero, highlights how artificial intelligence, real-time monitoring, and historical data can aid in optimizing trial design.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback